- info@myglp1store.com
- +1 (904) 942-2327
- 6953 Powers avenue suite 19 Jacksonville Fl 32217
Need Any Help?
+1 (904) 942-2327
+1 (904) 942-2327
$75.00
Tirzepatide is a synthetic dual-agonist formulation manufactured with a focus on quality, purity, and consistent formulation standards. It is produced under controlled processes to ensure stable composition and dependable quality.
| Component | Description |
|---|---|
| Active Ingredient | Tirzepatide (synthetic dual-agonist formulation) |
| Net Content | 5 mg per vial |
| Form | Lyophilized powder |
| Excipients | None added unless otherwise specified |
| Quality Verification | Identity and purity independently confirmed using validated analytical methods such as HPLC or mass spectrometry |
Tirzepatide has well-characterized structural properties. References to published literature are provided for informational purposes only and do not constitute usage, dosage, or clinical guidance.
This product is intended for research purposes only. It is designated strictly for in vitro testing and laboratory experimentation and is not approved for human or animal consumption. All information provided on this website is for educational and informational purposes only. This product should be handled only by licensed and qualified professionals. It is not a drug, food, or cosmetic, and must not be misbranded, misused, or mislabeled as such.
Tirzepatide 5 mg is a synthetic dual-agonist formulation produced with a focus on purity, consistency, and verified quality standards. Its dual-activity profile at GLP-1 and GIP pathways is manufactured under controlled processes to ensure stable composition and dependable quality across batches.
Tirzepatide features a well-characterized dual-agonist molecular structure. Each batch is prepared under strict quality control systems to ensure consistent formulation and reliable specifications.
Dual-agonist molecular profile (GLP-1 and GIP pathways)
Verified formulation consistency
Independently verified for purity and composition
Controlled manufacturing and handling standards
Transparent documentation available
Each vial contains 5 mg of lyophilized Tirzepatide. Store under recommended cold-storage conditions to maintain stability and integrity. Handle using standard procedures. Appropriate preparation and storage guidance is provided to maintain compound quality.
No medical, therapeutic, or physiological outcomes are implied or guaranteed.
All references to structural or analytical properties are provided for informational purposes only and do not constitute usage, dosage, or clinical guidance.
Tirzepatide is a synthetic dual-agonist formulation manufactured with a focus on quality, purity, and consistent formulation standards. It is produced under controlled processes to ensure stable composition and dependable quality.
| Component | Description |
|---|---|
| Active Ingredient | Tirzepatide (synthetic dual-agonist formulation) |
| Net Content | 5 mg per vial |
| Form | Lyophilized powder |
| Excipients | None added unless otherwise specified |
| Quality Verification | Identity and purity independently confirmed using validated analytical methods such as HPLC or mass spectrometry |
Tirzepatide has well-characterized structural properties. References to published literature are provided for informational purposes only and do not constitute usage, dosage, or clinical guidance.
Reviews
There are no reviews yet.